Reference |
---|
Hjortebjerg R, Espelund U, Rasmussen T, Folkersen B, Steiniche T, Georgsen J, et al. Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer. Front Endocrinol (Lausanne). 2020;11:614 pubmed publisher
|
Polyzos S, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis A, et al. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020;105: pubmed publisher
|
DiPrisco B, Kumar A, Kalra B, Savjani G, Michael Z, Farr O, et al. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019;100:153959 pubmed publisher
|
Hada M, Oh H, Pfeiffer R, Falk R, Fan S, Mullooly M, et al. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy. Breast Cancer Res. 2019;21:81 pubmed publisher
|
Anastasilakis A, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, et al. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019;51:112-119 pubmed publisher
|
Al Khafaji H, Noer P, Alkharobi H, Alhodhodi A, Meade J, El Gendy R, et al. A characteristic signature of insulin-like growth factor (IGF) axis expression during osteogenic differentiation of human dental pulp cells (hDPCs): Potential co-ordinated regulation of IGF action. Growth Horm IGF Res. 2018;42-43:14-21 pubmed publisher
|
Cediel G, Rueda F, Oxvig C, Oliveras T, Labata C, de Diego O, et al. Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction. Cardiovasc Diabetol. 2018;17:63 pubmed publisher
|
Marouli E, Graff M, Medina Gomez C, Lo K, Wood A, Kjaer T, et al. Rare and low-frequency coding variants alter human adult height. Nature. 2017;542:186-190 pubmed publisher
|
Bøtkjær J, Borgbo T, Kløverpris S, Noer P, Oxvig C, Andersen C. Effect of pregnancy-associated plasma protein-A (PAPP-A) single-nucleotide polymorphisms on the level and activity of PAPP-A and the hormone profile in fluid from normal human small antral follicles. Fertil Steril. 2016;106:1778-1786.e8 pubmed publisher
|
Brohus M, Gorbunova V, Faulkes C, Overgaard M, Conover C. The Insulin-Like Growth Factor System in the Long-Lived Naked Mole-Rat. PLoS ONE. 2015;10:e0145587 pubmed publisher
|
Thomsen J, Hjortebjerg R, Espelund U, Ørtoft G, Vestergaard P, Magnusson N, et al. PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinoma. Oncotarget. 2015;6:32266-78 pubmed publisher
|
Bøtkjær J, Jeppesen J, Wissing M, Kløverpris S, Oxvig C, Mason J, et al. Pregnancy-associated plasma protein A in human ovarian follicles and its association with intrafollicular hormone levels. Fertil Steril. 2015;104:1294-301.e1 pubmed publisher
|
Becker M, Haluska P, Bale L, Oxvig C, Conover C. A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts. Mol Cancer Ther. 2015;14:973-81 pubmed publisher
|
Jepsen M, Kløverpris S, Mikkelsen J, Pedersen J, Füchtbauer E, Laursen L, et al. Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. J Biol Chem. 2015;290:3430-9 pubmed publisher
|
Davidge Pitts C, Escande C, Conover C. Preferential expression of PAPPA in human preadipocytes from omental fat. J Endocrinol. 2014;222:87-97 pubmed publisher
|
Mikkelsen J, Resch Z, Kalra B, Savjani G, Kumar A, Conover C, et al. Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity. Oncotarget. 2014;5:1014-25 pubmed
|
Boldt H, Bale L, Resch Z, Oxvig C, Overgaard M, Conover C. Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice. Endocrinology. 2013;154:246-52 pubmed publisher
|